英國NextGen Sciences  www.nextgensciences.com
Nextgen Sciences公司總部位于英國的劍橋郡，分部設(shè)在美國的波士頓，該公司主要為蛋白質(zhì)研究提供整體解決方案。其產(chǎn)品為全自動、大型蛋白質(zhì)組學(xué)研究設(shè)備，包括三類設(shè)備：蛋白表達(dá)系統(tǒng)、自動雙向電泳系統(tǒng)、蛋白芯片工作站。該公司現(xiàn)與德國Protagen AG 公司（1999年成立，專注于蛋白質(zhì)組學(xué)研究實驗技術(shù)。）建立合作伙伴關(guān)系。增強(qiáng)了其在蛋白質(zhì)表達(dá)領(lǐng)域的實力。

NextGen Group PLC (LSE:NGG) is a provider of protein biomarker services, biomarkerexpress™, for pharmaceutical and biotech companies globally.

NextGen's range of services, which include biomarker discovery, assay development and a testing laboratory, are employed by customers as a key part of the drug and diagnostic development process. NextGen uses advanced and proprietary techniques to develop accurate, precise and robust biomarker assays, which are used to test pre-clinical and clinical samples for drug efficacy and safety, and for the development of personalised treatment for patients.
As well as biomarker services, NextGen also has a range of capabilities on offer to clients, including protein identification, characterization, quantitation and proteome mapping, and has an enviable record for providing high-quality fast results.
NextGen's management team has a track record of progressing technology solutions and delivering first-class services to market, and the company has worked with 16 of the top 20 pharmaceutical companies and has several Master Service Agreements in place.
NextGen continues to invest in cutting-edge technologies and form strategic alliances to offer the best quality and most comprehensive protein biomarker services to its pharmaceutical and biotech customers.